Pharmacist and PhD in biological sciences. Professor at the Institute for the Study of Inborn Errors of Metabolism at Pontificia Universidad Javeriana (Bogotá, Colombia) and cofounder of Dogma Biotech. His research focuses on the development of innovative therapies for lysosomal diseases, including recombinant protein-based treatments, gene therapy using viral and nonviral vectors, and CRISPR/Cas9 genome editing. He has also contributed to the discovery of pharmacological chaperones for lysosomal enzymes and to the application of bioinformatic tools in drug discovery and development. He is a corresponding member of the Colombian Academy of Exact, Physical and Natural Sciences and has received several recognitions for his scientific and entrepreneurial contributions, including the Innpacta Innovation Award, the QB3 Early-Stage Mentoring Program Award (University of California, Berkeley), and distinctions from the National Academy of Medicine of Colombia and the Alejandro Ángel Escobar Foundation. His work is aimed at advancing translational research and developing accessible therapeutic alternatives for patients affected by rare genetic diseases.